Business Context and Reporting Period
Company: SANUWAVE Health, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: April 17, 2020
Event: Entry into a Material Definitive Agreement regarding a Brazilian joint venture.
Key Financial Metrics
This filing does not contain financial performance data. No revenue, profit, cash flow, margins, debt, or liquidity figures are reported in this document.
Material Changes
On April 17, 2020, the Company entered into a shareholders agreement with Universus Global Advisors LLC, Versani Health Consulting Consultoria em Gestão de Negócios EIRELI, and IDIC Participações Ltda. This agreement regulates the rights and obligations of shareholders in Diversa S.A. ("Diversa"), a recently formed Brazilian joint venture.
- The agreement was contemplated by a joint venture agreement filed on January 28, 2020.
- Material terms are consistent with the previously disclosed joint venture agreement.
- The joint venture will have a four-member board: two members appointed by SANUWAVE Health, Inc. and two by IDIC Participações Ltda.
- The agreement includes specific rights upon a change of control of the Company.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, outlook, or management commentary regarding future performance. No specific risks or contingencies are detailed beyond the structural terms of the shareholders agreement.
Investor Verification Checklist
- Review the Joint Venture Agreement filed on January 28, 2020, and the Form 10-K filed on March 30, 2020, for full context on the Diversa S.A. structure.
- Verify the specific rights and obligations granted to each shareholder under the new agreement.
- Confirm the composition and appointment process for the four-member board of Diversa S.A.
- Assess the implications of the "change of control" provisions for SANUWAVE Health, Inc. shareholders.